UBS Group »

Portage Biotech shares owned by UBS Group

Quarter-by-quarter ownership of Portage Biotech (PRTG) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Portage Biotech

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 2917k18k19k250030003500
Value ($)Share countHistorical PRTG position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Portage Biotech held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Portage Biotech by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $19k 3.6k 5.33
2024-09-30 $16k 2.5k 6.60

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Portage Biotech

Lakeview Capital Partners
Citadel Advisors
UBS Group
Jpmorgan Chase & Co
Morgan Stanley
Royal Bank of Canada
SBI Securities
BlackRock
National Bank Of Canada /fi/
Credit Agricole
Wells Fargo & Company
CWM
Princeton Global Asset Management
Bnp Paribas Arbitrage, Snc

View all funds holding Portage Biotech